IDNAvsSPMD
iShares Genomics Immunology and Healthcare ETF against SPDR Portfolio S&P 400 Mid Cap ETF — the fee, the flows, the book, and a year head-to-head.
Head to head
| IDNA | SPMD | |
|---|---|---|
| Expense ratio | 0.47% | 0.030% |
| Assets | $340M | $18.8B |
| Net flow, 1 month | +$36M | +$250M |
| Net flow, 1 year | +$138M | +$2.5B |
| Return, YTD | +49.9% | +9.9% |
| Return, 1 year | — | — |
| Avg daily volume | 163K | 2.6M |
| Holdings | 50 | 400 |
| Listed | Jun 11, 2019 | Nov 8, 2005 |
| Options market | Yes | Yes |
MARKED CELLS LEAD ON THAT LINE · LOWER FEE, LARGER ASSETS, STRONGER FLOWS & RETURNS